ZYXI News and Press, Zynex Inc. From 08/03/23

Zynex, Inc Founder and CEO Thomas Sandgaard to participate in Benzinga's Pharma Companies vs. A Tough Macro Backdrop Free Webinar on August 3rd at 12:15 PM ET PR Newswire ENGLEWOOD, Colo. , Aug. 3, 2023 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medica...

2023-07-27 20:14:20 ET Zynex, Inc. (ZYXI) Q2 2023 Earnings Conference Call July 27, 2023, 04:15 PM ET Company Participants Quinn Callanan - Investor Relations Thomas Sandgaard - Chairman, President and Chief Executive Officer Anna Lucsok - Chief Operating Off...

2023-07-27 17:05:40 ET Zynex press release ( NASDAQ: ZYXI ): Q2 GAAP EPS of $0.09 beats by $0.05 . Revenue of $44.95M (+22.3% Y/Y) beats by $0.29M . The growth in net revenue is primarily related to a 51% growth in device orders, which resulted from an increase...

Zynex Reports Second Quarter 2023 Financial Results PR Newswire Q2 2023 Revenue increased 22% to $45.0 Million ; EPS $0.09 ENGLEWOOD, Colo. , July 27, 2023 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specia...

Zynex, Inc. Sets Second Quarter 2023 Earnings Call PR Newswire ENGLEWOOD, Colo. , July 20, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...

Zynex, Inc. (NASD: ZYXI) Wins 2023 National Top Workplaces Award in the Manufacturing Industry Category PR Newswire ENGLEWOOD, Colo. , July 17, 2023 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufactu...

2023-07-16 03:33:02 ET Summary Zynex, a medical device manufacturer, has reported a 36% year-over-year increase in revenue in Q1 2023, reaching $42.2 million, with a 14% increase in net income. Despite short-term underperformance, the company shows strong profitability and growth ...

2023-07-12 10:24:31 ET Zynex ( NASDAQ: ZYXI ) reiterates its full year 2023 guidance of revenue between $180 - $200M vs. consensus of $192.68M and EPS between $0.40 - $0.50 vs. consensus of $0.45. The Co. continues to see strong growth in its pain management division a...

Zynex Reports Preliminary Second Quarter 2023 Results PR Newswire ENGLEWOOD, Colo. , July 12, 2023 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices f...

Zynex, Inc. Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communication Program PR Newswire ENGLEWOOD, Colo. , July 10, 2023 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manu...